The data also highlights its mechanism of action ... And then they're on lifelong immunosuppressive therapies, cyclophosphamide, steroids, mTOR inhibitors, things like that.

The US Food and Drug Administration said the ROCKET phase 2 trial can restart under a revised protocol using JCAR015 T-cells with cyclophosphamide ... co-stimulatory mechanism as JCAR015.

In March 2025, Celgene announced a study is to compare the effectiveness and safety of golcadomide in combination with ...

SUZHOU, China, March 27, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today reported 2024 annual ...

Jeff Jones; Analyst; Oppenheimer & Co., Inc. Aydin Huseynov; Analyst; Ladenburg Thalmann & Co. Inc. Good afternoon, everyone. Thank you for standing by and welcome to the Corvus Pharmaceuticals ...

MoA All America Fund earns an Average Process Pillar rating. The predominant contributor to the rating is its parent firm's superior long-term risk-adjusted performance, as shown by the firm's ...

The profitability screen requires that the sum of a company’s GAAP earnings over the past four quarters be positive as well as the most recent quarter. The screen imparts a slight quality tilt ...

Stanway said doubts remain about Juno's candidate, nevertheless, particularly as rival Kite said it had no concerns about using fludarabine in combination with cyclophosphamide at low dose during ...

Acute myeloid leukemia is a type of cancer that starts inside bone marrow, the soft tissue inside bones that helps form blood cells. The cancer develops from myeloid blasts cells that would ...

Behçet's disease (BD) is a systemic large-vessel vasculitis characterized by a wide clinical spectrum including recurrent oral and genital ulcerations, uveitis, and vascular, neurological ...